By Business/Source
Currency:USD
2025/Q3
Stock NameRevenueRatio
Laboratory services83.93M99.84%
Therapeutic Development138K0.16%
By Country/Region
Currency:USD
2024/FY
Stock NameRevenueRatio
United States259.13M91.41%
China12.64M4.46%
Foreign11.7M4.13%